Since the start of COVID-19 in 2020, the demand for online medical services has soared, and the internet medical service, which has been lingering on, has sprang up. With the advantages of no contact, quick response and breakthrough of geographical space, the internet medical platform has been accepted by the market quickly, and ushered in the real spring.

According to the China Internet Medical annual analysis 2020 report, the scale of the internet medical market in 2020 was nearly 200 billion yuan, an increase of 46.7%, reaching the highest growth rate since 2015. At the same time, with the support of a series of preferential policies, internet medical care has accelerated.

In December 2020, JD health officially landed on the Hong Kong stock exchange, becoming the third listed internet medical and health platform in China after ping an good doctor and Ali health.

In April 2021, Weiyi Holdings Co., Ltd. submitted a listing prospectus, which triggered a heated debate in the industry as the first share of digital medicine.

At the end of August of the same year, Zhiyun health went to Hong Kong to submit a prospectus, which once again attracted the attention of the industry.

The prospectus was submitted in June. Yingtong technology, which passed the hearing in September, has begun its public offering and is expected to be listed on November 5. The "first share of AI medical" is about to be born. Since 2021, medical AI enterprises represented by Shukun technology, Keya medical, and Fanxiang technology have also submitted prospectuses, one step away from IPO.

Over the years, internet medical has many financing, large volume and rapid development. Now, together with medical AI enterprises, internet medical has also ushered in a wave of listing. On October 15, Yuanxin technology submitted a prospectus to the Hong Kong stock exchange. Previously, from April to August 2021, Weiyi, Dingdang health, Zhiyun health and Sipai health submitted prospectus one after another, and the "digital medical first share" of Weiyi and the "digital chronic disease management first share" of Zhiyun health were ready to emerge.

After nearly 10 years of development of Internet healthcare, enterprises have raised billions of dollars, many of which have exceeded $10 billion in valuation, but their profitability still hasn't kept up. Over the past three years, the net losses of the above four enterprises have exceeded 2 billion yuan, and the losses of Zhiyun health have reached 4.5 billion yuan. Burn money as much as online education.

At present, internet medical treatment has enabled many people to talk to doctors in class III hospitals in real time without leaving home, so that patients with sudden colds and fever can enjoy home delivery of drugs within half an hour, and patients with chronic diseases can also go back to visit and prescribe drugs online.

However, the problem is that it is difficult to see a clear effect of the management and services proud of Internet medicine. In addition to light consultation, professional medical problems are difficult to solve online. Therefore, after the completion of the closed loop from registered consultation to health management in the first half, Internet enterprises began to lay out offline and occupy more entrances. At the same time, they began to think about how to truly implement their business, solve patients' problems and do valuable things.

What is the development basis of these internet medical enterprises? What fields does its industrial chain include at present? How should internet medical enterprises go well in the second half?